Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ActiNovo is a German nutraceutical company specializing in the development and manufacturing of high-bioavailability liquid supplements using advanced liposomal encapsulation technology. By encapsulating active ingredients such as Vitamin C, Glutathione, and Curcumin within lipid vesicles, the company aims to bypass the digestive system's degradation processes and ensure direct delivery into the bloodstream. ActiNovo operates as a brand under PlantaCorp GmbH, providing both direct-to-consumer products and white-label manufacturing services for the global health and wellness market. Their focus remains on scientific validation of nutrient absorption and the scaling of liposomal production for various health applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Actinovo.